Cardlytics Proceeds Revenue Contraction In The Middle Of Failing Business Economics (NASDAQ: CDLX)

.Financial writer encourages marketing Cardlytics, Inc. because of decreasing device economics, profits challenges, and also adverse monetary patterns. Click on for this CDLX improve.